SCN5A and Supraventricular tachycardia: Also in support of a targeted approach, flecainide, an Nav1.5 blocker used to treat supraventricular tachycardias, is more effective in suppressing atrial arrhythmias in the setting of reduced Pitx2c mRNA levels in mice (83).